Focus on the drug release platform and glycomics

PLATFORM PRODUCT POTENTIAL INDICATION CURRENT STATUS FORECAST MILESTONES
ISM
ISM
Risperidone ISM® Schizophrenia
 III
 I - Preclinical

Phase II successfully completed

Start of Phase III clinical trial in May 2017

Start of Phase I in 2nd half of 2017

Letrozole ISM® Breast cancer
Glicomics
Glicomics
Enoxaparin
biosimilar
Thromboembolic venous disease
 III

Registration phase